investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Role of Pharmacogenetics on Exemestane Metabolism and Toxicity

Philip Lazarus

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Philip Lazarus

Massachusetts General Hospital

Boston, United States

Washington State University

Pullman, United States

Related projects

Ron N Alkalay

Lesion-specific QCT Improves Prediction of Pathologic Vertebrae Fracture Load

Breast

Gary E Fraser

Plant-Based Diets and Risk of Cancer

Breast

Nola M Hylton-Watson

Quantitative Imaging for Assessing Breast Cancer Response to Treatment

Breast

Wong-Ho Chow

Racial/ethnic disparity in breast cancer: can metabolic profiles play a role?

Breast

Global Noncommunicable Diseases Intiatives

Support program in the fight against cancer - Experts fund

Breast

Wei Zheng

Consortium Study to Identify Breast Cancer Susceptibility Loci

Breast

Esther M John

Breast Cancer Family Registry Cohort

Breast

Pathology

Global Noncommunicable Diseases Intiatives

The Project for Improvement of Medical Equipment for Breast Cancer Screening in Menouf City, Monofeya

Breast

Charles D Blanke

SWOG Community Clinical Oncology Program Research Base

Breast